Archon Biosciences

Archon Biosciences is a Seattle-based biotechnology company pioneering computationally designed Antibody Cages (AbCs) to advance drug development. Spun out of the Baker Lab at the University of Washington Institute for Protein Design—the lab whose foundational work was recognized by the 2024 Nobel Prize in Chemistry—Archon directly applies generative protein design to rapidly manufacture a new biologic class. AbCs combine off-the-shelf antibodies with AI-generated protein structures that self-assemble into exquisitely precise nanostructures, providing unique control over biodistribution and target engagement. The company's platform enables rapid exploration of previously intractable drug discovery challenges and is backed by $20M in seed financing led by Madrona Ventures.